Serum cathepsin S is associated with serum C-reactive protein and interleukin-6 independently of obesity in elderly men

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages 4460-4464

  Jobs, E ^a,d   Riserus U ^b   Ingelsson, E ^a,c   Helmersson, J ^b   Nerpin, E ^a,d   Jobs, M ^d   Sundstrom J ^b   Lind, L ^b   Larsson, A ^b   Basu, S ^b   Arnlov J ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d DALARNA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CATHEPSIN S; CHOLESTEROL; CYSTATIN C; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; CATHEPSIN;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LEISURE; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADULT; BLOOD; COHORT ANALYSIS; DEMOGRAPHY; LONGITUDINAL STUDY;

ADULT; AGED; C-REACTIVE PROTEIN; CATHEPSINS; COHORT STUDIES; HUMANS; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; OBESITY; RESIDENCE CHARACTERISTICS;

EID: 77956588680     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0328     Document Type: Article

References (20)

1. Chapman HA, Riese RJ, Shi GP 1997 Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88
2. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA 1999 Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10:197-206
3. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP 2004 Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24:1359-1366
4. Taleb S, Cancello R, Poitou C, Rouault C, Sellam P, Levy P, Bouillot JL, Coussieu C, Basdevant A, Guerre-Millo M, Lacasa D, Clement K 2006 Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women. J Clin Endocrinol Metab 91:1042-1047
5. Taleb S, Lacasa D, Bastard JP, Poitou C, Cancello R, Pelloux V, Viguerie N, Benis A, Zucker JD, Bouillot JL, Coussieu C, Basdevant A, Langin D, Clement K 2005 Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 19:1540-1542
6. Geraghty P, Greene CM, O'Mahony M, O'Neill SJ, Taggart CC, McElvaney NG 2007 Secretory leucocyte protease inhibitor inhibits interferon-γ-induced cathepsin S expression. J Biol Chem 282:33389-33395
7. Gupta S, Singh RK, Dastidar S, Ray A 2008 Cysteine cathepsin S as an immunomodulatory target: present and future trends. Expert Opin Ther Targets 12:291-299
8. Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, Murakami M, Hirano T 2005 IL-6-STAT3 controls intracellular MHC class II αβ dimer level through cathepsin S activity in dendritic cells. Immunity 23:491-502
9. Liuzzo JP, Petanceska SS, Moscatelli D, Devi LA 1999 Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions. Mol Med 5:320-333
10. Ovchinnikova O, Robertson AK, Wågsäter D, Folco EJ, Hyry M, Myllyharju J, Eriksson P, Libby P, Hansson GK 2009 T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apo E(-/-) mice. Am J Pathol 174:693-700
11. Pan JH, Sukhova GK, Yang JT, Wang B, Xie T, Fu H, Zhang Y, Satoskar AR, David JR, Metz CN, Bucala R, Fang K, Simon DI, Chapman HA, Libby P, Shi GP 2004 Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109:3149-3153
12. Williams AS, Eynott PR, Leung SY, Nath P, Jupp R, De Sanctis GT, Resnick R, Adcock IM, Chung KF 2009 Role of cathepsin S in ozone-induced airway hyperresponsiveness and inflammation. Pulm Pharmacol Ther 22:27-32
13. Byberg L, Zethelius B, McKeigue PM, Lithell HO 2001 Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia 44:2134-2139
14. Helmersson J, Larsson A, Vessby B, Basu S 2005 Active smoking and a history of smoking are associated with enhanced prostaglandin F(2α), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 181:201-207
15. Byberg L, Siegbahn A, Berglund L, McKeigue P, Reneland R, Lithell H 1998 Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. Arterioscler Thromb Vasc Biol 18:258-264
16. Fissolo N, Kraus M, Reich M, Ayturan M, Overkleeft H, Driessen C, Weissert R 2008 Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. Eur J Immunol 38:2401-2411
17. Zheng T, Kang MJ, Crothers K, Zhu Z, Liu W, Lee CG, Rabach LA, Chapman HA, Homer RJ, Aldous D, De Sanctis GT, Underwood S, Graupe M, Flavell RA, Schmidt JA, Elias JA 2005 Role of cathepsin S-dependent epithelial cell apoptosis in IFN-γ-induced alveolar remodeling and pulmonary emphysema. J Immunol 174:8106-8115
18. Schwarz G, Boehncke WH, Braun M, Schröter CJ, Burster T, Flad T, Dressel D, Weber E, Schmid H, Kalbacher H 2002 Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-γ. J Invest Dermatol 119:44-49
19. Fajardo I, Svensson L, Bucht A, Pejler G 2004 Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med 170:477-484
20. Weidauer E, Yasuda Y, Biswal BK, Cherny M, James MN, Brömme D 2007 Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S. Biol Chem 388:331-336